"N Engl J Med"[journal] 检索结果

4801. Early Amino Acids in Extremely Preterm Infants and Neurodisability.

作者: Song Mao.
来源: N Engl J Med. 2023年388卷4期382页

4802. Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. Reply.

作者: Steven J Russell.;Edward R Damiano.;Peter Calhoun.
来源: N Engl J Med. 2023年388卷4期380-382页

4803. Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.

作者: Teck K Khoo.
来源: N Engl J Med. 2023年388卷4期380页

4804. Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.

作者: Yuki Murata.;Morihito Takita.;Masahiro Kami.
来源: N Engl J Med. 2023年388卷4期380页

4805. Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.

作者: Jason A Dominitz.;Douglas J Robertson.
来源: N Engl J Med. 2023年388卷4期379页

4806. Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.

作者: Michael Bretthauer.;Magnus Løberg.;Michal F Kaminski.
来源: N Engl J Med. 2023年388卷4期378-379页

4807. Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.

作者: Mitchell S Cappell.;Martin Tobi.;Yu-Xiao Yang.
来源: N Engl J Med. 2023年388卷4期378页

4808. Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.

作者: Michael Hoffmeister.;Rafael Cardoso.;Hermann Brenner.
来源: N Engl J Med. 2023年388卷4期377-378页

4809. Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.

作者: Sidney J Winawer.; .
来源: N Engl J Med. 2023年388卷4期377页

4810. Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.

作者: Wilber Deck.
来源: N Engl J Med. 2023年388卷4期376-377页

4811. Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.

作者: James A Hanley.
来源: N Engl J Med. 2023年388卷4期376页

4812. Covid Vaccines - Playing the Long Game.

来源: N Engl J Med. 2023年388卷4期e5页

4813. Another Victory for Patients with Hemophilia.

作者: Cindy Leissinger.
来源: N Engl J Med. 2023年388卷4期372-373页

4814. Extracorporeal CPR in Out-of-Hospital Cardiac Arrest - Still on Life Support?

作者: John F Keaney.;Thomas Münzel.
来源: N Engl J Med. 2023年388卷4期370-371页

4815. Case 3-2023: A 16-Year-Old Girl with Abdominal Pain and Bloody Diarrhea.

作者: Stacy A Kahn.;Maureen M Leonard.;Sjirk J Westra.;Jonathan S Hausmann.;Sarah B Mueller.
来源: N Engl J Med. 2023年388卷4期358-368页

4816. Atopic Eruption of Pregnancy.

作者: Masakazu Kakurai.;Kazumasa Oya.
来源: N Engl J Med. 2023年388卷4期357页

4817. Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV.

作者: Ahizechukwu C Eke.;Mark Mirochnick.;Shahin Lockman.
来源: N Engl J Med. 2023年388卷4期344-356页

4818. Cystatin C-Based Equation to Estimate GFR without the Inclusion of Race and Sex.

作者: Hans Pottel.;Jonas Björk.;Andrew D Rule.;Natalie Ebert.;Björn O Eriksen.;Laurence Dubourg.;Emmanuelle Vidal-Petiot.;Anders Grubb.;Magnus Hansson.;Edmund J Lamb.;Karin Littmann.;Christophe Mariat.;Toralf Melsom.;Elke Schaeffner.;Per-Ola Sundin.;Anna Åkesson.;Anders Larsson.;Etienne Cavalier.;Justine B Bukabau.;Ernest K Sumaili.;Eric Yayo.;Dagui Monnet.;Martin Flamant.;Ulf Nyman.;Pierre Delanaye.
来源: N Engl J Med. 2023年388卷4期333-343页

The accuracy of estimation of kidney function with the use of routine metabolic tests, such as measurement of the serum creatinine level, has been controversial. The European Kidney Function Consortium (EKFC) developed a creatinine-based equation (EKFC eGFRcr) to estimate the glomerular filtration rate (GFR) with a rescaled serum creatinine level (i.e., the serum creatinine level is divided by the median serum creatinine level among healthy persons to control for variation related to differences in age, sex, or race). Whether a cystatin C-based EKFC equation would increase the accuracy of estimated GFR is unknown.

4819. Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A.

作者: Annette von Drygalski.;Pratima Chowdary.;Roshni Kulkarni.;Sophie Susen.;Barbara A Konkle.;Johannes Oldenburg.;Davide Matino.;Robert Klamroth.;Angela C Weyand.;Victor Jimenez-Yuste.;Keiji Nogami.;Stacey Poloskey.;Bent Winding.;Annemieke Willemze.;Karin Knobe.; .
来源: N Engl J Med. 2023年388卷4期310-318页

Efanesoctocog alfa provides high sustained factor VIII activity by overcoming the von Willebrand factor-imposed half-life ceiling. The efficacy, safety, and pharmacokinetics of efanesoctocog alfa for prophylaxis and treatment of bleeding episodes in previously treated patients with severe hemophilia A are unclear.

4820. Early Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest.

作者: Martje M Suverein.;Thijs S R Delnoij.;Roberto Lorusso.;George J Brandon Bravo Bruinsma.;Luuk Otterspoor.;Carlos V Elzo Kraemer.;Alexander P J Vlaar.;Joris J van der Heijden.;Erik Scholten.;Corstiaan den Uil.;Tim Jansen.;Bas van den Bogaard.;Marijn Kuijpers.;Ka Yan Lam.;José M Montero Cabezas.;Antoine H G Driessen.;Saskia Z H Rittersma.;Bram G Heijnen.;Dinis Dos Reis Miranda.;Gabe Bleeker.;Jesse de Metz.;Renicus S Hermanides.;Jorge Lopez Matta.;Susanne Eberl.;Dirk W Donker.;Robert J van Thiel.;Sakir Akin.;Oene van Meer.;José Henriques.;Karen C Bokhoven.;Loes Mandigers.;Jeroen J H Bunge.;Martine E Bol.;Bjorn Winkens.;Brigitte Essers.;Patrick W Weerwind.;Jos G Maessen.;Marcel C G van de Poll.
来源: N Engl J Med. 2023年388卷4期299-309页

Extracorporeal cardiopulmonary resuscitation (CPR) restores perfusion and oxygenation in a patient who does not have spontaneous circulation. The evidence with regard to the effect of extracorporeal CPR on survival with a favorable neurologic outcome in refractory out-of-hospital cardiac arrest is inconclusive.

结果排序

文献格式

出版时间

出版类型

出版语言